Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
16.78
-0.11 (-0.65%)
Aug 31, 2026, 10:06 AM EDT - Market open
IART Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,305 | 967 | 1,750 | 3,405 | 4,683 | 5,674 | |
Market Cap Growth | 12.65% | -44.72% | -48.60% | -27.30% | -17.47% | 3.71% |
Enterprise Value | 3,081 | 2,707 | 3,464 | 4,800 | 5,872 | 6,918 |
Last Close Price | 16.89 | 12.42 | 22.68 | 43.55 | 56.07 | 66.99 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 50.26 | 25.94 | 33.56 |
Forward PE | 6.59 | 5.21 | 8.83 | 12.94 | 16.16 | 20.19 |
PS Ratio | 0.80 | 0.59 | 1.09 | 2.21 | 3.01 | 3.68 |
PB Ratio | 1.26 | 0.93 | 1.13 | 2.14 | 2.60 | 3.37 |
P/FCF Ratio | 50.91 | - | 70.10 | 46.58 | 21.08 | 21.46 |
P/OCF Ratio | 15.39 | 19.20 | 13.53 | 24.33 | 17.71 | 18.16 |
PEG Ratio | 1.38 | 18.37 | 6.17 | 1.54 | 1.68 | 1.36 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.88 | 1.66 | 2.15 | 3.11 | 3.77 | 4.49 |
EV/EBITDA Ratio | 9.75 | 9.09 | 10.73 | 20.42 | 16.44 | 21.63 |
EV/EBIT Ratio | 18.91 | 18.55 | 19.04 | 43.04 | 24.58 | 34.59 |
EV/FCF Ratio | 119.74 | - | 138.75 | 65.68 | 26.44 | 26.16 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.97 | 1.95 | 1.29 | 1.06 | 0.90 | 1.01 |
Debt / EBITDA Ratio | 6.00 | 6.33 | 5.72 | 6.50 | 4.25 | 5.00 |
Debt / FCF Ratio | 79.46 | - | 79.57 | 23.03 | 7.27 | 6.43 |
Net Debt / Equity Ratio | 1.70 | 1.70 | 1.11 | 0.87 | 0.64 | 0.70 |
Net Debt / EBITDA Ratio | 5.60 | 5.95 | 5.31 | 5.85 | 3.24 | 3.71 |
Net Debt / FCF Ratio | 68.83 | -57.04 | 68.61 | 18.80 | 5.22 | 4.49 |
Asset Turnover | 0.46 | 0.43 | 0.41 | 0.40 | 0.41 | 0.42 |
Inventory Turnover | 1.49 | 1.55 | 1.59 | 1.84 | 1.83 | 1.91 |
Quick Ratio | 1.64 | 1.19 | 0.59 | 1.85 | 2.24 | 2.23 |
Current Ratio | 3.60 | 2.54 | 1.17 | 3.45 | 3.62 | 3.39 |
Return on Equity (ROE) | -0.70% | -39.90% | -0.44% | 3.99% | 10.35% | 10.57% |
Return on Assets (ROA) | 2.83% | 2.39% | 2.91% | 1.82% | 3.89% | 3.38% |
Return on Invested Capital (ROIC) | 5.80% | 4.81% | 5.85% | 3.15% | 6.91% | 5.56% |
Return on Capital Employed (ROCE) | 5.10% | 4.60% | 5.80% | 3.20% | 6.70% | 5.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -0.55% | -53.39% | -0.40% | 1.99% | 3.86% | 2.98% |
FCF Yield | 1.96% | -3.21% | 1.43% | 2.15% | 4.74% | 4.66% |
Buyback Yield / Dilution | -0.56% | 0.44% | 4.14% | 3.81% | 2.30% | -0.30% |